“GLP-1 drugs don’t just change what people eat,” Karthik Srinivasan, communications strategy consultant, tells Invezz.They change whether people want to eat at all. That’s why this stops being a marketing problem and becomes a business-model problem for a whole lot of categories.The weight-loss drug boom didn’t just spark a health…
Indian stocks, especially the nation’s tech sector, will likely face turbulence in the first half of 2026, according to…
The Trump administration on Thursday unveiled what it called the “Great Healthcare Plan,” a broad framework aimed at addressing…
Europe enters the week with a mix of economic resilience and geopolitical strain.Britain’s stronger-than-expected growth has lifted market confidence,…
Global markets and politics are colliding as power, technology, and capital flow come under renewed strain.In the United States,…
Investors are piling into Galaxy Digital (NASDAQ: GLXY) this morning, but the enthusiasm does not really have anything to…
The United States and Taiwan struck a trade agreement Thursday that aims to mobilize up to $500 billion in…
Three US House Democrats are accusing the Securities and Exchange Commission of stepping back from its enforcement role in…
The Nifty 50 Index remained on edge on Friday as investors waited for the upcoming earnings by some of…